tirzepatide court case today Lilly Suffers Legal Loss in Against Compounding Pharmacy Eli Lilly's tirzepatide is off
Description
Data is not
The starting dose is often part of the adjustment phase, but treatment plans vary by individual
This is a proposed rule, not yet finalized
The most common gastrointestinal side effects include nausea (17-30% of patients), diarrhea (15-23%), constipation (11-17%), vomiting, and abdominal discomfort
Patients who depended on affordable compounded versions suddenly faced uncertainty about continued access
